BSE filing, NSE: M3GLOBAL. Summary written from the filing by ALFA Finder's alert engine.
Niyogin Fintech Ltd: key numbers
- Share price
- ₹43.98
- Market cap
- ₹488.1 Cr
- Revenue (annual)
- ₹286.9 Cr
- Net profit (annual)
- ₹-0.47 Cr
- P/E (TTM)
- -291.9×Sector 19.8×
- Promoter holding
- 39.50%+0.00% QoQ
- FII holding
- 19.53%Current quarter
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
More from Niyogin Fintech Ltd
All →Niyogin Fintech Merger & Restructuring
Niyogin Fintech's equity shareholders met on 30 October 2026 to approve a composite demerger and amalgamation scheme. Scrutinizer results will follow.
Niyogin Fintech Other Announcement
Niyogin Fintech Ltd filed its quarterly shareholding pattern as per Regulation 31(1)(b). This is a standard periodic compliance disclosure.
Niyogin Fintech Debt & Borrowing
Niyogin Fintech Ltd confirmed the interest payment status for its 12.60% non-convertible debentures due on October 19, 2026.
Niyogin Fintech Debt & Borrowing: ₹0.33 Cr
Niyogin Fintech Ltd has confirmed the successful payment of interest on its non-convertible debentures. The payment of Rs.0.33 Crore was made on the due date.
- Value
- ₹0.33 Cr
Niyogin Fintech Annual General Meeting
Niyogin Fintech issued an AGM notice for September 23, 2026. Agenda includes financial adoption and the ₹11.75 Crore stake sale of subsidiary Investdirect Capital.
- Value
- ₹11.75 Cr
Niyogin Fintech Merger & Restructuring
Niyogin Fintech has scheduled court-convened meetings for shareholders and creditors on October 30, 2026, to vote on its composite scheme of arrangement and amalgamation.
Other regulatory approval announcements
All →Nesco Regulatory Approval
Nesco Limited received a Commencement Certificate from BMC for Tower-2 and Hall-1 at Nesco Center, Goregaon. The company can now proceed with construction and development of the proposed projects, valid until 29 October 2027.
Grasim Industries Regulatory Approval
CCI approved subsidiary ABReN's acquisition of 100% of Solenergi Power from Shell Overseas. The approval clears a regulatory condition for the deal announced on 13 July 2026.
Vedavaag Systems Regulatory Approval
Vedavaag's WOS received IRDAI Certificate of Registration to act as Direct Life & General Insurance Broker. The group enters regulated insurance broking activity.
Hikal Regulatory Approval
Hikal's Bengaluru API facility received a Swissmedic GMP Certificate of Compliance. The certification supports wider access to European and other regulated markets.
Sun Pharmaceutical Industries Regulatory Approval
Sun Pharma gained US FDA approval for ILUMYA in adults with active psoriatic arthritis. The approval extends the drug's psoriasis use, with no financial value stated.
RNFI Services Regulatory Approval
RNFI received RBI no-objection to acquire control of Smart Payment Solutions Private Limited. Remaining tranches may proceed, but no transaction value is disclosed.